Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00782366 | Predictive Genetic Risk Assessment Trial(PGT) | completed | — | 26 | Mayo ClinicOTHER | 1 | Apr 27, 2011 | clinicaltrials |
| NCT00006112 | Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer | unknown | Phase 2 | — | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Apr 26, 2011 | clinicaltrials |
| NCT01340508 | Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer | unknown | Phase 2 | 63 | National University Hospital, SingaporeOTHER | 1 | Apr 22, 2011 | clinicaltrials |
| NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Apr 18, 2011 | clinicaltrials |
| NCT00351572 | Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients | completed | — | 30 | Alberta Health servicesOTHER | 1 | Apr 18, 2011 | clinicaltrials |
| NCT00713128 | Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy | completed | — | 50 | Steward St. Elizabeth's Medical Center of Boston, Inc.OTHER | 1 | Apr 12, 2011 | clinicaltrials |
| NCT01330186 | Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy | unknown | — | 50 | Copenhagen University Hospital at HerlevOTHER | 1 | Apr 12, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT00004102 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00005050 | Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT01012804 | Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer | withdrawn | — | 0 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00622999 | Effects of Malnutrition on Colon Cancer Patients With Abdominal Surgery | completed | — | 186 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Mar 11, 2011 | clinicaltrials |
| NCT00859768 | The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients | completed | N/A | 568 | Netherlands Open UniversityOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00893503 | Scope Pilot Research Study(SCOPE) | completed | — | 1,248 | University of AlbertaOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00040820 | Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer | completed | N/A | — | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00900835 | Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer | completed | N/A | 470 | City of Hope Medical CenterOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT01305980 | Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | SBPharmaceutical IND, Co., LTDINDUSTRY | 1 | Mar 4, 2011 | clinicaltrials |
| NCT00118755 | A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 435 | Hoffmann-La RocheINDUSTRY | 0 | Mar 3, 2011 | clinicaltrials |
| NCT00977613 | Adherence to a Recommended Exercise Regimen in Colorectal Cancer Patients | completed | N/A | 50 | Beth Israel Medical CenterOTHER | 1 | Mar 3, 2011 | clinicaltrials |
| NCT00646139 | KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment | completed | Phase 1 | 7 | Roswell Park Cancer InstituteOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT00950144 | Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer | completed | — | 123 | City of Hope Medical CenterOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT01303393 | Information Needs After Surgery for Colorectal Cancer | completed | — | 100 | Region SkaneOTHER | 1 | Feb 24, 2011 | clinicaltrials |
| NCT01282658 | Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRC(PSIFL) | unknown | — | 200 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 17, 2011 | clinicaltrials |
| NCT01157806 | Palliative Radiochemotherapy Against Palliative Surgery in Stage IV Rectal Cancer With Unresectable Metastases | unknown | Phase 2 | 20 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Feb 16, 2011 | clinicaltrials |
| NCT01183156 | Re-invitation to Screening Colonoscopy: a Randomized Study(REINVITE) | unknown | N/A | 1,000 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Feb 16, 2011 | clinicaltrials |
| NCT00192075 | A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer | completed | Phase 2 | 84 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 7, 2011 | clinicaltrials |
| NCT00007618 | The Identification of Prognostic Factors of Late Stage Disease, Particularly Those That Are Modifiable, That Might Explain the Worsened Prognosis With Colorectal Cancer Among Veterans. | completed | — | — | US Department of Veterans AffairsFED | 1 | Feb 3, 2011 | clinicaltrials |
| NCT00441311 | Dissemination of Colorectal Cancer Screening to Primary Care Physicians | completed | Phase 4 | 264 | Columbia UniversityOTHER | 1 | Feb 1, 2011 | clinicaltrials |
| NCT01286064 | Colorectal Cancer Detection by Means of Optical Fluoroscopy | unknown | N/A | 200 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jan 31, 2011 | clinicaltrials |
| NCT01286662 | A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome | completed | — | 105 | Triemli HospitalOTHER | 0 | Jan 31, 2011 | clinicaltrials |
| NCT00003365 | Sulindac and Plant Compounds in Preventing Colon Cancer | terminated | N/A | — | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00233623 | Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer | withdrawn | Phase 2 | 190 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00207051 | BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies | completed | Phase 1 | 62 | Bristol-Myers SquibbINDUSTRY | 3 | Jan 25, 2011 | clinicaltrials |
| NCT00113776 | Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Jan 21, 2011 | clinicaltrials |
| NCT01279278 | Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?(Pagedocc1) | unknown | N/A | 2,700 | University of Paris 5 - Rene DescartesOTHER | 1 | Jan 19, 2011 | clinicaltrials |
| NCT01279330 | Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?(Pagedocc2) | unknown | N/A | 1,569 | University of Paris 5 - Rene DescartesOTHER | 1 | Jan 19, 2011 | clinicaltrials |
| NCT00145314 | FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer | completed | Phase 3 | 571 | The Nordic Colorectal Cancer Biomodulation GroupOTHER | 1 | Jan 14, 2011 | clinicaltrials |
| NCT01271166 | Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer | terminated | Phase 1 | 10 | Novartis PharmaceuticalsINDUSTRY | 1 | Jan 6, 2011 | clinicaltrials |
| NCT01271192 | Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer(NARC) | unknown | N/A | 360 | Sun Yat-sen UniversityOTHER | 1 | Jan 6, 2011 | clinicaltrials |
| NCT00191984 | A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 5, 2011 | clinicaltrials |
| NCT00410579 | Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers | completed | — | 744 | NSABP Foundation IncNETWORK | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01261962 | Modulation of Immune Response by Oral Zinc Supplementation in Chemotherapy for Colon Cancer | unknown | N/A | 60 | University of Sao PauloOTHER | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01262417 | Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion Formation(SEPRAC2T) | completed | Phase 2 | 60 | Centre Leon BerardOTHER | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01116154 | Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma | terminated | Phase 1 | 30 | City of Hope Medical CenterOTHER | 1 | Dec 9, 2010 | clinicaltrials |
| NCT01251237 | Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies | completed | Phase 2 | 120 | NorgineINDUSTRY | 1 | Dec 1, 2010 | clinicaltrials |
| NCT00228189 | Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients | completed | Phase 1 / Phase 2 | 30 | Radboud University Medical CenterOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00784667 | Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib(Dux) | unknown | Phase 2 | 50 | Austin HealthOTHER_GOV | 1 | Nov 30, 2010 | clinicaltrials |
| NCT01249521 | Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer(Vengeance) | unknown | Phase 2 | 40 | Austin HealthOTHER_GOV | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00386828 | Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial | completed | Phase 2 | 43 | British Columbia Cancer AgencyOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT01144195 | A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy(ACTIVE) | unknown | Phase 2 | 80 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socialsOTHER | 1 | Nov 10, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Apr 27, 2011source: clinicaltrials